Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy ; volume:66 ; number:12 ; day:29 ; month:9 ; year:2023 ; pages:2307-2319 ; date:12.2023
Diabetologia ; 66, Heft 12 (29.9.2023), 2307-2319, 12.2023
- Creator
-
Taskinen, Marja-Riitta
Matikainen, Niina
Björnson, Elias
Söderlund, Sanni
Inkeri, Jussi
Hakkarainen, Antti
Parviainen, Helka
Sihlbom, Carina
Thorsell, Annika
Andersson, Linda
Adiels, Martin
Packard, Chris J.
Borén, Jan
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00125-023-06008-0
- URN
-
urn:nbn:de:101:1-2024012309084303534824
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Taskinen, Marja-Riitta
- Matikainen, Niina
- Björnson, Elias
- Söderlund, Sanni
- Inkeri, Jussi
- Hakkarainen, Antti
- Parviainen, Helka
- Sihlbom, Carina
- Thorsell, Annika
- Andersson, Linda
- Adiels, Martin
- Packard, Chris J.
- Borén, Jan
- SpringerLink (Online service)
Other Objects (12)
Pla2g12b drives expansion of triglyceride-rich lipoproteins
Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?
Publisher Correction: Pla2g12b drives expansion of triglyceride-rich lipoproteins
Statin effects on atherosclerotic plaques: regression or healing?
Managing of Dyslipidaemia Characterized by Accumulation of Triglyceride-Rich Lipoproteins
Residual risks and evolving atherosclerotic plaques
Comparative Analysis of Atherogenic Lipoproteins L5 and Lp(a) in Atherosclerotic Cardiovascular Disease
Apolipoprotein E synthesized by adipocyte and apolipoprotein E carried on lipoproteins modulate adipocyte triglyceride content
Initiation of statin therapy halts progression of atherosclerotic plaque burden in peripheral arterial disease
Oxylipins in triglyceride-rich lipoproteins of dyslipidemic subjects promote endothelial inflammation following a high fat meal
Human plasma lipoproteins
Blood Lipoproteins Shape the Phenotype and Lipid Content of Early Atherosclerotic Lesion Macrophages: A Dual-Structured Mathematical Model
Pla2g12b drives expansion of triglyceride-rich lipoproteins
Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?
Publisher Correction: Pla2g12b drives expansion of triglyceride-rich lipoproteins
Statin effects on atherosclerotic plaques: regression or healing?
Managing of Dyslipidaemia Characterized by Accumulation of Triglyceride-Rich Lipoproteins
Residual risks and evolving atherosclerotic plaques
Comparative Analysis of Atherogenic Lipoproteins L5 and Lp(a) in Atherosclerotic Cardiovascular Disease
Apolipoprotein E synthesized by adipocyte and apolipoprotein E carried on lipoproteins modulate adipocyte triglyceride content
Initiation of statin therapy halts progression of atherosclerotic plaque burden in peripheral arterial disease
Oxylipins in triglyceride-rich lipoproteins of dyslipidemic subjects promote endothelial inflammation following a high fat meal
Human plasma lipoproteins
Blood Lipoproteins Shape the Phenotype and Lipid Content of Early Atherosclerotic Lesion Macrophages: A Dual-Structured Mathematical Model
Pla2g12b drives expansion of triglyceride-rich lipoproteins
Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?
Publisher Correction: Pla2g12b drives expansion of triglyceride-rich lipoproteins
Statin effects on atherosclerotic plaques: regression or healing?
Managing of Dyslipidaemia Characterized by Accumulation of Triglyceride-Rich Lipoproteins
Residual risks and evolving atherosclerotic plaques
Comparative Analysis of Atherogenic Lipoproteins L5 and Lp(a) in Atherosclerotic Cardiovascular Disease
Apolipoprotein E synthesized by adipocyte and apolipoprotein E carried on lipoproteins modulate adipocyte triglyceride content
Initiation of statin therapy halts progression of atherosclerotic plaque burden in peripheral arterial disease
Oxylipins in triglyceride-rich lipoproteins of dyslipidemic subjects promote endothelial inflammation following a high fat meal
Human plasma lipoproteins